Literature DB >> 8423113

Standardizing methodologies for economic evaluation in health care. Practice, problems, and potential.

M Drummond1, A Brandt, B Luce, J Rovira.   

Abstract

There has been an exponential growth in the literature on economic evaluation in health care. As the range and quality of analytical work has improved, economic studies are becoming more influential with health care decision makers. The development of standards for economic evaluation methods would help maintain the scientific quality of studies, facilitate the comparison of economic evaluation results for different health care interventions, and assist in the interpretation of results from setting to setting. However, standardization might unnecessarily stifle methodological developments. This paper reviews the arguments for and against standardization, assesses attempts to date, outlines the main areas of agreement and disagreement on methods for economic evaluation, and makes recommendations for further work.

Mesh:

Year:  1993        PMID: 8423113     DOI: 10.1017/s0266462300003007

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  52 in total

Review 1.  Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Authors:  M J Postma; R M Baltussen; M L Heijnen; L T de Berg; J C Jager
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

2.  Guidelines for appropriate care: the importance of empirical normative analysis.

Authors:  M Berg; R T Meulen; M van den Burg
Journal:  Health Care Anal       Date:  2001

Review 3.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 4.  The role of government and private insurers in guiding and implementing pharmacoeconomic analyses.

Authors:  D A Freund; B R Luce
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

Review 5.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  S Byford; S Palmer
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

Review 6.  The economic cost of epilepsy: a review.

Authors:  M Brunetti; E Pagano; L Garattini
Journal:  Ital J Neurol Sci       Date:  1998-04

7.  Standardisation of costs: the Dutch Manual for Costing in economic evaluations.

Authors:  Jan B Oostenbrink; Marc A Koopmanschap; Frans F H Rutten
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  The impact of health economics on healthcare delivery. A primary care perspective.

Authors:  D P Kernick
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

9.  The NICE reference case requirement: implications for drug manufacturers and health systems.

Authors:  Paul C Langley
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Cost-effectiveness analysis: obstacles to standardisation and its use in regulating pharmaceuticals.

Authors:  B R Luce
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.